全般発作治療のグローバル臨床試験動向(2014年H2)...市場調査レポートについてご紹介

【英文タイトル】Generalized Seizures Global Clinical Trials Review, H2, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Generalized Seizures 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Generalized Seizures to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Generalized Seizures to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Generalized Seizures 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Generalized Seizures Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
UCB S.A. 32
Clinical Trial Overview of UCB S.A. 32
Johnson & Johnson 34
Clinical Trial Overview of Johnson & Johnson 34
Pfizer Inc. 35
Clinical Trial Overview of Pfizer Inc. 35
Novartis AG 36
Clinical Trial Overview of Novartis AG 36
Eisai Co., Ltd. 37
Clinical Trial Overview of Eisai Co., Ltd. 37
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
Mylan Inc. 39
Clinical Trial Overview of Mylan Inc. 39
Dr. Reddy’s Laboratories Limited 40
Clinical Trial Overview of Dr. Reddy’s Laboratories Limited 40
Desitin Arzneimittel GmbH 41
Clinical Trial Overview of Desitin Arzneimittel GmbH 41
Boehringer Ingelheim Auslandsbeteiligungs GmbH 42
Clinical Trial Overview of Boehringer Ingelheim Auslandsbeteiligungs GmbH 42
Clinical Trial Overview of Top Institutes / Government 43
National Institute of Neurological Disorders and Stroke 43
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 43
University Hospital Freiburg 44
Clinical Trial Overview of University Hospital Freiburg 44
Capital District Health Authority, Canada 45
Clinical Trial Overview of Capital District Health Authority, Canada 45
Emory University 46
Clinical Trial Overview of Emory University 46
Hadassah Medical Organization 47
Clinical Trial Overview of Hadassah Medical Organization 47
Massachusetts General Hospital 48
Clinical Trial Overview of Massachusetts General Hospital 48
U.S. Department of Veterans Affairs 49
Clinical Trial Overview of U.S. Department of Veterans Affairs 49
Maastricht University Medical Center 50
Clinical Trial Overview of Maastricht University Medical Center 50
Assistance Publique – Hopitaux de Paris 51
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 51
Gillette Children’s Specialty Healthcare 52
Clinical Trial Overview of Gillette Children’s Specialty Healthcare 52
Five Key Clinical Profiles 53
Appendix 119
Abbreviations 119
Definitions 119
Research Methodology 120
Secondary Research 120
About GlobalData 121
Contact Us 121
Disclaimer 121
Source 121


【レポート販売概要】

■ タイトル:全般発作治療のグローバル臨床試験動向(2014年H2)
■ 英文:Generalized Seizures Global Clinical Trials Review, H2, 2014
■ 発行日:2014年7月14日
■ 調査会社:GlobalData
■ 商品コード:GDHC2233CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。